Digest Network Come funziona
Network
/
Società
Co
Non verificato

Coya Therapeutics, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteScienza

41 comunicati stampa

Guarda tutti i comunicati
09/12/2025
Industria
Scienza
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Coya Therapeutics Announces Patients Have Been Dosed in the ALSTARS Trial of COYA 302 for the Treatment of ALS
Fonte
Coya Therapeutics, Inc.
Emittente
Business Wire
1.00
0
25/11/2025
Eventi
Web e Social Network
Salute
Medicina - Varie
Scienza
Biotecnologia
Coya Therapeutics to Participate in Upcoming Investor Relations and Clinical Trials Conferences
Fonte
Coya Therapeutics, Inc.
Emittente
Business Wire
1.00
0
12/11/2025
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Mercato azionario
Coya Therapeutics Reports Third Quarter Financial Results and Provides a Corporate Update
Fonte
Coya Therapeutics, Inc.
Emittente
Business Wire
1.00
0
04/11/2025
Coya Therapeutics Announces That Its Combination LD IL-2/GLP-1 RA Candidate (COYA 303) Demonstrated Potent Systemic and Brain Anti-Inflammatory Efficacy In Vivo
Fonte
Coya Therapeutics, Inc.
Emittente
Business Wire
1.00
0
27/10/2025
Finanza
Comunicazione
Biotecnologia
Medicina - Varie
Associazioni/Professionisti
Salute
Coya Therapeutics Announces Closing of $23.0 Million Upsized Public Offering of Common Stock, Including Full Exercise of Underwriter’s Option to Purchase Additional Shares
Fonte
Coya Therapeutics, Inc.
Emittente
Business Wire
1.00
0
24/10/2025
Finanza
Scienza
Biotecnologia
Farmaceutica
Salute
Igiene alimentare
Medicina - Varie
Coya Therapeutics Announces Pricing of $20 Million Upsized Public Offering of Common Stock
Fonte
Coya Therapeutics, Inc.
Emittente
Business Wire
1.00
0
23/10/2025
Mercato azionario
Salute
Biotecnologia
Medicina - Varie
Sanità
Farmaceutica
Coya Therapeutics Announces Proposed Public Offering of Common Stock
Fonte
Coya Therapeutics, Inc.
Emittente
Business Wire
1.00
0
07/10/2025
Scienza
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Mercato del lavoro
Eventi
Coya Therapeutics Congratulates Scientific Advisor Dr. Shimon Sakaguchi for Receiving The Nobel Prize in Physiology or Medicine for Discovery of Regulatory T Cells and Immune Function
Fonte
Coya Therapeutics, Inc.
Emittente
Business Wire
1.00
0
24/07/2025
Salute
Vetrine/Shopping
Terza età
Farmaceutica
Biotecnologia
Industria
Coya Therapeutics Announces Publication of Scientific Research Linking Inflammation and Oxidative Stress to the Progression of Parkinson’s Disease
Fonte
Coya Therapeutics, Inc.
Emittente
Business Wire
1.00
0
22/07/2025
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Eventi
Coya Therapeutics to Participate in the BTIG Virtual Biotechnology Conference July 29 – 30, 2025
Fonte
Coya Therapeutics, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0